Maureen Rischmueller

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

Andrea Rubbert‐Roth, Jeffrey Enejosa, Aileen L. Pangan et al. · New England Journal of Medicine · 2020 · 281 citations

Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome

Sally A. Waterman, Tom P. Gordon, Maureen Rischmueller · Arthritis & Rheumatism · 2000 · 239 citations

Sicca Syndrome, Muscarinic Receptor Autoantibodies, Immunology +25

Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate‐Naive Patients With Moderately‐to‐Severely Active Rheumatoid Arthritis (SELECT‐EARLY): A Multicenter, Multi‐Country, Randomized, Double‐Blind, Active Comparator–Controlled Trial

Ronald van Vollenhoven, Tsutomu Takeuchi, Aileen L. Pangan et al. · Arthritis & Rheumatology · 2020 · 216 citations · Full text

Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double‐blind, placebo‐controlled, dose‐escalating, single‐ and repeated‐dose study

P. P. Tak, Rogier M. Thurlings, C. Rossier et al. · Arthritis & Rheumatism · 2007 · 205 citations